Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures

Although vaccines are currently used to control the coronavirus disease 2019 (COVID‐19) pandemic, treatment options are urgently needed for those who cannot be vaccinated and for future outbreaks involving new severe acute respiratory syndrome coronavirus virus 2 (SARS‐CoV‐2) strains or coronaviruse...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Winston, Verschueren, Lore, Van den Eynde, Christel , Buyck, Christophe, De Meyer, Sandra, Jochmans, Dirk, Bojkova, Denisa, Ciesek, Sandra, Cinatl, Jindrich, De Jonghe, Steven, Leyssen, Pieter, Neyts, Johan, Van Loock, Marnix, Van Damme, Ellen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088669/
https://www.ncbi.nlm.nih.gov/pubmed/35229317
http://dx.doi.org/10.1002/jmv.27683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9088669/
https://www.ncbi.nlm.nih.gov/pubmed/35229317
http://dx.doi.org/10.1002/jmv.27683

Ejemplares similares